Mirum Pharmaceuticals, Inc. (MIRM)
Develops medicines for rare liver and genetic diseases with limited treatment options.
$109.18-0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+109.9%
The outlook
MIRM is trading near the upper end of its 52-week range, comfortably above both its 50- and 200-day moving averages. Analyst consensus is strongly bullish, with an average price target roughly 34% above the current price. The stock shows technical strength, though today's movement is flat.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 14 analysts
Price trendAbove its 50- & 200-day averages
52-week range74% of the way from its 52-week low to high
Price targetAvg target +34% vs current price
Analyst price target
~12-month · 14 analysts$146.50average target+34.2% vs now
Now $109.18
Low $125.00High $185.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$6.66B
52-wk high
$130.00
52-wk low
$50.25
50-day avg
$108.71
200-day avg
$91.97
Trailing P/E
—